Treatment of uveitis with recombinant human interleukin-13

British Journal of Ophthalmology

Volumn 82, Issue 10, 1998, Pages 1195-1198

  Roberge, François G ^a,d   De Smet, Marc D ^a   Benichou, Jacques ^b   Kriete, Martin F ^a   Raber, James ^a   Hakimi, John ^c  

^a NATIONAL EYE INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1; RETINA S ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; DISEASE COURSE; FEMALE; FOLLOW UP; IMMUNIZATION; INFLAMMATION OF THE EYE AND SURROUNDING STRUCTURES; LEUKOCYTE; LYMPHOCYTE; MONKEY; NEUTROPHIL; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UVEITIS;

EID: 0031715273     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.10.1195     Document Type: Article

References (30)

1. Rubin B, Palestine AG. Complications of corticosteroids and immunosuppressive drugs. Int Ophthalmol Clin 1989;29:159-71.
2. Towler HM, Whiting PH, Forrester JV. Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye 1990;4:514-20.
3. Mochizuki M, Masuda K, Sakane T, et al. A clinical trial of FK506 in refractory uveitis. Am J Ophthalmol 1993;115: 763-9.
4. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
5. De Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993;151: 6370-81.
6. Doherty TM, Kastelein R, Menon S, et al. Modulation of murine macrophage function by IL-13. J Immunol 1993;151:7151-60.
7. Cosentino G, Soprana E, Thienes CP, et al. IL-13 down-regulates CD14 expression and TNF-alpha secretion in normal human monocytes. J Immunol 1995;155: 3145-51.
8. Endo T, Ogushi F, Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-gamma. J Immunol 1996;156:2240-6.
9. Onoe Y, Miyaura C, Kaminakayashiki T, et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. J Immunol 1996;156:758-64.
10. Jacobsen SE, Okkenhaug C, Veiby OP, et al. Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoieytic progenitor cells. J Exp Med 1994;180:75-82.
11. Lai YH, Heslan JM, Poppema S, et al. Continuous administration of 11-13 to mice induces extramedullary hemopoiesis and monocytosis. J Immunol 1996;156:3166-73.
12. Skeen MJ, Miller MA, Shinnick TM, et al. Regulation of murine macrophage IL-12 production. J Immunol 1996; 156:1196-206.
13. Guex-Crosier Y, Raber J, Chan C-C, et al. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. J Immunol 1997;158:452-8.
14. Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
15. SAS/STAT user's guide. Version 6. 4th ed. Cary, NC: SAS Institute Inc, 1989:891-996.
16. Marfaing-Koka A, Devergne O, Gorgone G, et al Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. J Immunol 1995;154:1870-8.
17. Durum S, Oppenheim JJ. Proinflammatory cytokines and immunity. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1993:801-35.
18. Murray PI, Hoekzema R, van Haren MAC, et al. Aqueous humor interleukin-6 levels in uveitis. Invest Ophthalmol Vis Sci 1990;31:917-20.
19. Wu WC-S, Mannion B, Stone RM. Uveitis associated with interleukin-3 and interleukine-6 therapy. Arch Ophthalmol 1995;113:408-9.
20. Roberge FG, Caspi RR, Nussenblatt RB. Glial retinal Muller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. J Immunol 1988;140:2193-6.
21. de Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res 1992;11:581-97.
22. Guex-Crosier Y, Wittwer AJ, Roberge FG. Intraocular production of a cytokine (CINC) responsible for neutrophil infiltration in endotoxin-induced uveitis. Br J Ophthalmol 1996;80:649-52.
23. Rosenbaum JT. Towards cytokine insight in sight. Br J Ophthalmol 1995;79:970-1.
24. Deschenes J, Char DH, Kaleta S. Activated T lymphocytes in uveitis. Br J Ophthalmol 1988;72:83-7.
25. Chan C-C, Nussenblatt RB, Fujikawa LS, et al. Sympathetic ophthalmia. Immunopathological findings. Ophthalmology 1986;93:690-5.
26. Chan C-C, Wetzig RP, Palestine AG, et al. Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis. Arch Ophthalmol 1987;105: 1398-402.
27. Chan CC, Palestine AG, Kuwabara T, et al. Immunopathological study of Vogt-Koyanagi-Harada syndrome: report of a case. Am J Ophthalmol 1988;105:607-11.
28. Vitale AT, Rodriguez A, Foster SC. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology 1996;103:365-74.
29. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
30. Cash E, Minty A, Ferrara P, et al. Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 1994;153:4258-67.